MichelleAElliottMD

PubMed

• 3 citations
  One thousand patients with essential thrombocythemia: the Mayo Clinic experience.
  Karrar, O., Ketterling, R., Gangat, N., Al-Kali, A., Begna, K., Elliott, M., Wolanskyj-Spinner, A., Pardanani, A., Hanson, C., Tefferi, A.> ;Blood Cancer Journal. 2024 Jan 18
• 3 citations
  Mast cell cytomorphology and treatment outcome in mast cell leukemia.
  Ayalew Tefferi, Animesh Pardanani, Aref Al-Kali, Hassan Alkhateeb, Kristen McCullough, Mrinal Patnaik, William J Hogan, Kebede Begna, Michelle A Elliott, Nandita Khera...> ;American Journal of Hematology. 2024 Jan 1
• 4 citations
  Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
  Animesh Pardanani, Ayalew Tefferi, Aref Al-Kali, Mrinal Patnaik, William J Hogan, Kebede Begna, Michelle A Elliott, Nandita Khera, Jeanne M Palmer, Naseema Gangat, Att...> ;American Journal of Hematology. 2024 Jan 1
• 1 citations
  Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arte...
  Maymona G Abdelmagid, Aref Al-Kali, Mark R Litzow, Kebede H Begna, William J Hogan, Mirinal S Patnaik, Shahrukh K Hashmi, Michelle A Elliott, Hassan Alkhateeb, Omer S ...> ;Blood Cancer Journal. 2023 Aug 11
• 2 citations
  Bortezomib and daratumumab in refractory autoimmune hemolytic anemia.
  Jithma Abeykoon, Eyad Al-Hattab, Aneel A Ashrani, Michelle Elliott, C Christopher Hook, Animesh Pardanani, Rajiv Pruthi, Meera Sridharan, Alexandra Wolanskyj, Rachelle...> ;American Journal of Hematology. 2023 Oct 1
• 1 citations
  Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
  Mostafa Abdallah, Kristen McCullough, Rimal Ilyas, Kebede H Begna, Aref Al-Kali, Mark R Litzow, William J Hogan, Abhishek Mangaonkar, Hassan Alkhateeb, Mithun V Shah, ...> ;Blood Cancer Journal. 2023 Mar 13
• 2 citations
  TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases.
  Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al ...> ;American Journal of Hematology. 2023 Apr 1
• 5 citations
  Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm.
  Naseema Gangat, Rimal Ilyas, Kristen McCullough, Kebede H Begna, Aref Al-Kali, Mrinal M Patnaik, Mark R Litzow, William J Hogan, Abhishek Mangaonkar, Hassan Alkhateeb,...> ;Haematologica. 2023 May 1
• 3 citations
  Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real-world setting.
  Amritpal Singh, Aref Al-Kali, James M Foran, Michelle A Elliott, Kebede Begna, Talha Badar, Nandita Khera, Farah Fleti, Maymona Abdelmagid, Kareen K Reichard, Rhett P ...> ;American Journal of Hematology. 2022 Oct 1
• 4 citations
  Site-specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival.
  Naseema Gangat, Amritpal Singh, Natasha Szuber, Kebede Begna, Michelle Elliott, Alexandra Wolanskyj-Spinner, Curtis A Hanson, Animesh Pardanani, Valerio De Stefano, Ti...> ;Journal of Thrombosis and Haemostasis. 2022 Oct 1
• 4 citations
  1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events.
  Naseema Gangat, Natasha Szuber, Yamna Jadoon, Faiqa Farrukh, Kebede Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Curtis A Hanson, Animesh D Pardanani, Val...> ;Blood Advances. 2022 Jul 12
• 8 citations
  Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms.
  Mithun Vinod Shah, Abhishek A Mangaonkar, Kebede H Begna, Hassan B Alkhateeb, Patricia Greipp, Ahmad Nanaa, Michelle A Elliott, William J Hogan, Mark R Litzow, Kristen...> ;Blood Cancer Journal. 2022 Jul 8
• 7 citations
  A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
  Ayalew Tefferi, Naseema Gangat, Aref Al-Kali, Hassan Alkhateeb, Mithun Shah, Mrinal S Patnaik, Michelle A Elliott, William J Hogan, Mark R Litzow, Christopher C Hook, ...> ;American Journal of Hematology. 2022 Sep 1
• 24 citations
  Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.
  Liewei Wang, Steven E Scherer, Suzette J Bielinski, Donna M Muzny, Leila A Jones, John Logan Black 3rd, Ann M Moyer, Jyothsna Giri, Richard R Sharp, Eric T Matey, Jess...> ;Genetics in Medicine. 2022 May 1
• 3 citations
  Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3".
  K H Begna, X Xu, N Gangat, H Alkhateeb, M M Patnaik, A Al-Kali, M A Elliott, W J Hogan, M R Litzow, C C Hook, A P Wolanskyj-Spinner, A Mangaonkar, R He, A Pardanani, M...> ;Blood Cancer Journal. 2022 Apr 7
• 12 citations
  Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
  Natasha Szuber, Michelle Elliott, Ayalew Tefferi> ;American Journal of Hematology. 2022 Apr 1
• 6 citations
  Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience.
  Faiqa Farrukh, Naseema Gangat, Mithun V Shah, Mark R Litzow, Michelle A Elliott, Kebede Begna, Christopher C Hook, Ayalew Tefferi, Animesh Pardanani> ;American Journal of Hematology. 2022 Apr 1
• 5 citations
  European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response.
  K H Begna, J Kittur, N Gangat, H Alkhateeb, M S Patnaik, A Al-Kali, M A Elliott, W J Hogan, M R Litzow, A Pardanani, C A Hanson, R P Ketterling, A Tefferi> ;Blood Cancer Journal. 2022 Jan 17
• 12 citations
  Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases.
  Ayalew Tefferi, Jaya Kittur, Faiqa Farrukh, Kebede H. Begna, Mrinal M. Patnaik, Aref Al-Kali, Michelle A. Elliott, Kaaren K. Reichard, Naseema Gangat, Animesh Pardanani> ;British Journal of Haematology. 2021 Nov 3
• 13 citations
  Characteristics and outcome of patients with core binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.
  Sabine Kayser, Michael Kramer, David Martínez-Cuadrón, Justin Grenet, Klaus H. Metzeler, Zuzana Šustková, Marlise R. Luskin, Andrew M. Brunner, Michelle A. Elliott, Cr...> ;Haematologica. 2021 Aug 5
• 8 citations
  De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases.
  Kebede H. Begna, Jaya Kittur, Jennifer C. Yui, Naseema Gangat, Mrinal M. Patnaik, Aref Al-Kali, Michelle A. Elliott, William J. Hogan, Mark R. Litzow, C. Christopher H...> ;British Journal of Haematology. 2021 Aug 3
• 18 citations
  Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients.
  Marissa Li, Moritz Binder, Terra L. Lasho, Alejandro Ferrer, Naseema Gangat, Aref Al-Kali, Abhishek A. Mangaonkar, Michelle A. Elliott, Mark R. Litzow, William R. Hoga...> ;Blood Advances. 2021 Apr 27
• 42 citations
  Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
  Naseema Gangat, Paola Guglielmelli, Natasha Szuber, Kebede H. Begna, Mrinal M. Patnaik, Mark R. Litzow, Aref Al-Kali, James M. Foran, Jeanne Palmer, Hassan B. Alkhatee...> ;American Journal of Hematology. 2021 Jul 1
• 4 citations
  CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes.
  Evandro D. Bezerra, Terra L. Lasho, Christy Finke, Antoine N. Saliba, Michelle A. Elliott, Animesh Pardanani, Naseema Gangat, Abhishek A. Mangaonkar, Rhett P. Ketterli...> ;Blood Cancer Journal. 2021 Mar 11
• 8 citations
  Mayo Clinic experience with 1123 adults with acute myeloid leukemia.
  Kebede H. Begna, Walid Ali, Naseema Gangat, Michelle A. Elliott, Aref Al-Kali, Mark R. Litzow, C. Christopher Hook, Alexandra P. Wolanskyj-Spinner, William J. Hogan, M...> ;Blood Cancer Journal. 2021 Mar 2
• Join now to see all

Abstracts/Posters

• Clinical Categorization of Chronic Myelomonocytic Leukemia into Proliferative and Dysplastic Subtypes Correlates with Distinct Genomic, Transcriptomic and Epigenomic S...
  Michelle A Elliott, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Characteristics and Outcome of Patients with Core Binding Factor Acute Myeloid Leukemia and FLT3-ITD: Results from an International Collaboration
  Michelle A Elliott, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial
  Michelle A Elliott, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Survival Outcomes Following Allogeneic Stem Cell Transplantation for Inherited Bone Marrow Failure and Myeloid Germline Predisposition Syndromes
  Michelle A Elliott, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytos...
  Michelle A Elliott, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all